Thomas Bornemann

Thomas Bornemann is currently the Group Chief Financial Officer at Dr.Max Pharmacy Chain, a role they have held since 2017. Prior to this position, Thomas served as Managing Director at LloydsApotek, where they led efforts to foster growth and profitability within a competitive market. Their extensive experience includes roles as Finance Director for Gehe Pharma Praha and LloydsApotek, as well as positions within Celesio AG that encompassed corporate controlling responsibilities across multiple countries. Thomas earned an Executive Master of Business Administration with honors from ESMT European School of Management and Technology and holds various other financial certifications and degrees.